More Sichuan Huiyu Pharmaceutical Co. Ltd. Class A news
Sichuan Huiyu Pharmaceutical Co. Ltd. Class ASSE: 688553

Announcement on Expected Loss in Performance for 2025

Jan 30, 2026 · Issued by Sichuan Huiyu Pharmaceutical Co. Ltd. Class A via Shanghai Stock Exchange
Announcement on Expected Loss in Performance for 2025

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment